Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
February 08 2024 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a
biopharmaceutical company focused on the development and
commercialization of therapeutics for central nervous system (CNS)
disorders, today announced it will host a conference call and live
webcast discussion at 8:30 a.m. Eastern Time on Thursday, February
22, 2024, to provide a corporate update and discuss details of the
Company's financial results for the quarter and year ended December
31, 2023.
To attend the live conference call by phone please
use this registration link. All participants must use the link to
complete the online registration process in advance of the
conference call.
The live and archived webcast can be accessed under "Events
& Presentations" in the Investor Relations section of the
Company's website at www.intracellulartherapies.com. Please log in
approximately 5-10 minutes prior to the event to register and to
download and install any necessary software.
About Intra-Cellular TherapiesIntra-Cellular
Therapies is a biopharmaceutical company founded on Nobel
prize-winning research that allows us to understand how therapies
affect the inner-workings of cells in the body. The company
leverages this intracellular approach to develop innovative
treatments for people living with complex psychiatric and
neurologic diseases. For more information, please visit
www.intracellulartherapies.com.
Contact:Intra-Cellular Therapies, Inc.Juan Sanchez, M.D. Vice
President, Corporate Communications and Investor
Relations646-440-9333
Burns McClellan, Inc.Cameron
Radinoviccradinovic@burnsmc.com212-213-0006
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Apr 2024 to May 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From May 2023 to May 2024